Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
Huaqing Yan, Haiyun Xie, Yufan Ying, Jiangfeng Li, Xiao Wang, Xin Xu, Xiangyi Zheng Department of Urology, First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang Province, China Abstract: Pioglitazone has been reported to increase the risk of bladder cancer but the conclusions of publish...
Main Authors: | Yan H, Xie H, Ying Y, Li J, Wang X, Xu X, Zheng X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-06-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/pioglitazone-use-in-patients-with-diabetes-and-risk-of-bladder-cancer--peer-reviewed-article-CMAR |
Similar Items
-
Pioglitazone use and the risk of bladder cancer
by: Hsin-Wei Kuo, et al.
Published: (2014-02-01) -
The association between pioglitazone consumption and incidence of bladder cancer in type II diabetic patients: a systematic review and meta-analysis of observational studies
by: Pantea Ramezannezhad, et al.
Published: (2023-03-01) -
A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population
by: V Balaji, et al.
Published: (2014-01-01) -
The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
by: Sun Ok Song, et al.
Published: (2012-10-01) -
Pioglitazone and bladder cancer in human studies: Is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?
by: Chin-Hsiao Tseng
Published: (2012-03-01)